Supporting eye-disease diagnosis with retinal-image AI and genetic testing
Inherited retinal diseases can progressively impair vision. Diagnosis requires clinical assessment and retinal imaging, while genetic testing can confirm the cause and guide care. Interpreting genetic results also requires specialist expertise and counseling for patients and families.
Actyon Genomics offers A-Lens for AI analysis of retinal images, with optional genetic testing and expert support. Eye-care professionals upload fundus images or OCT scans, review downloadable reports and compare them with previous studies for follow-up.
What stands out about Actyon Genomics
Actyon reports more than 1,500 patients with genetic diseases diagnosed through its A-Vision genetic testing service.
Actyon reports A-Lens use by more than 120 professionals and integration at more than 10 clinics and hospitals in Ibero-America.
Actyon reports developing retinal-disease gene panels with Roche España, a concrete collaboration on its diagnostic offering.
The madri+d Startup Radar lists healthstart madri+d as Actyon's related incubator/accelerator.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.